Table 4 Cerebral venous sinus thrombosis
Variables | N = 15 |
|---|---|
Age | 56 ± 14.3 |
Gender (male) | 7 |
Risk factors | |
Comorbidities (≥1) | 2 |
Oral contraceptives | 2 |
D-dimer (mcg/mL), mean ± SD | 3698.4 ± 2017.3 |
Submassive pulmonary embolism | 1 |
CVT presentation | |
Altered mental status | 6 |
Headache | 8 |
Aphasia | 6 |
Hemiparesis | 7 |
Seizures | 4 |
At home | 9 |
COVID-19 clinical presentation | |
Fever | 3 |
Progressive dyspnea | 3 |
Asymptomatic | 3 |
Mild symptoms | 1 |
Pneumonia | 6 |
Computed tomography with CO-RADS 5 | 6 |
Thromboprophylaxis | 5 |
Treatment and outcomes | |
Unfractionated heparin | 3 |
Low-molecular-weight-heparin | 12 |
Intracranial hemorrhage | 7 |
Death | 3 |